| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
En Xian Sarah Low, Edhel Tripon, Kieron Lim, Poh Seng Tan, How Cheng Low, Yock Young Dan, Yin Mei Lee, Mark Muthiah, Wai Mun Loo, Calvin Jianyi Koh, Wah Wah Phyo, Junxiong Pang, Seng Gee Lim and Guan Huei Lee |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guan Huei Lee, MBBS, MRCP, PhD, Attending Doctor, Division of Gastroenterology and Hepatology, National University Health System, 1E, Kent Ridge Road, Singapore 119228, Singapore. guan_huei_lee@nuhs.edu.sg |
| Key Words |
Toxicity; Antiviral agents; Hepatitis E virus; Virus classification; Systemic immunity; Immune responses; Persistent infection |
| Core Tip |
Hepatitis E virus (HEV) infection is a cause of chronic hepatitis in immunosuppressed patients. Sustained virologic response (SVR) rate to a 12-wk course of ribavirin therapy was reported to be > 70% in the West. This study describes the outcome of HEV treatment in a transplant center in Singapore. Ten transplant recipients (liver, kidney, bone marrow transplantation) with positive HEV RNA are studied. The SVR rate of 12-wk ribavirin therapy for HEV infection in this Asian series is lower than expected - overall failure rate (66.7%). Kidney transplant recipients have more treatment failure due to higher immunosuppression requirements and adverse effects. |
| Publish Date |
2019-06-27 10:40 |
| Citation |
Low EXS, Tripon E, Lim K, Tan PS, Low HC, Dan YY, Lee YM, Muthiah M, Loo WM, Koh CJ, Phyo WW, Pang JX, Lim SG, Lee GH. Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection. World J Hepatol 2019; 11(6): 553-561 |
| URL |
https://www.wjgnet.com/1948-5182/full/v11/i6/553.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v11.i6.553 |
